US20220257716A1

Methods and compositions for the treatment of secretory disorders

University of Texas System

Abstract

The present invention relates to the treatment of secretory disorders, and provides novel methods of treatment of these disorders comprising the administration of fibroblast growth factor 21 (FGF21) or derivatives thereof. The methods of the invention are useful in conditions including exocrine …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: David J. Mangelsdorf
Priority date: May 25, 2016
Filing date: March 11, 2022
Publication date: August 18, 2022
Language: en
PDF source: https://patentimages.storage.googleapis.com/b7/6b/e4/641fde870dc74a/US20220257716A1.pdf
Metadata fetched: August 29, 2026 00:30